Sandy Dobbie
Directeur/Membre du Conseil chez NiTech Solutions Ltd.
Profil
Sandy Dobbie is currently a Director-Executive Board at Evolva SA and a Non-Executive Director at NiTech Solutions Ltd.
In the past, he worked as the Chairman of Synthace Ltd.
and as the Head-International Operations at Kelco Ltd.
for a brief period in 2001.
Postes actifs de Sandy Dobbie
| Sociétés | Poste | Début |
|---|---|---|
Evolva SA
 Evolva SA Miscellaneous Commercial ServicesCommercial Services Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers. | Corporate Officer/Principal | 18/11/2009 |
NiTech Solutions Ltd.
 NiTech Solutions Ltd. Industrial MachineryProducer Manufacturing NiTech Solutions Ltd. designs and offers continuous oscillatory baffled reactors and the tubular reactors for crystallization, biodiesel and hydrogenation applications. Its products DN15 HP Pilot Unit, DN15 HP PLUS, DN15 STANDARD and DN15 LITE serve pharmaceutical, chemical, biotechnology, waste management, and food and drink industries. The company was founded by Xiong-Wei Ni in December 2004 and is headquartered in Edinburgh, the United Kingdom. | Directeur/Membre du Conseil | - |
Anciens postes connus de Sandy Dobbie
| Sociétés | Poste | Fin |
|---|---|---|
Kelco Ltd.
 Kelco Ltd. Wholesale DistributorsDistribution Services Kelco Ltd. wholesales petroleum products. The firm services include gas stations, grocery stores and supermarkets. The company is located in Sevierville, TN. | Directeur des opérations | 01/01/2001 |
Synthace Ltd.
 Synthace Ltd. Packaged SoftwareTechnology Services Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom. | Président | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Evolva SA
Evolva SA Miscellaneous Commercial ServicesCommercial Services Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers. | Commercial Services |
NiTech Solutions Ltd.
NiTech Solutions Ltd. Industrial MachineryProducer Manufacturing NiTech Solutions Ltd. designs and offers continuous oscillatory baffled reactors and the tubular reactors for crystallization, biodiesel and hydrogenation applications. Its products DN15 HP Pilot Unit, DN15 HP PLUS, DN15 STANDARD and DN15 LITE serve pharmaceutical, chemical, biotechnology, waste management, and food and drink industries. The company was founded by Xiong-Wei Ni in December 2004 and is headquartered in Edinburgh, the United Kingdom. | Producer Manufacturing |
Kelco Ltd.
Kelco Ltd. Wholesale DistributorsDistribution Services Kelco Ltd. wholesales petroleum products. The firm services include gas stations, grocery stores and supermarkets. The company is located in Sevierville, TN. | Distribution Services |
Synthace Ltd.
Synthace Ltd. Packaged SoftwareTechnology Services Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom. | Technology Services |